246 related articles for article (PubMed ID: 20471507)
1. Basal bone phenotype and increased anabolic responses to intermittent parathyroid hormone in healthy male COX-2 knockout mice.
Xu M; Choudhary S; Voznesensky O; Gao Q; Adams D; Diaz-Doran V; Wu Q; Goltzman D; Raisz LG; Pilbeam CC
Bone; 2010 Aug; 47(2):341-52. PubMed ID: 20471507
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 suppresses the anabolic response to PTH infusion in mice.
Choudhary S; Canalis E; Estus T; Adams D; Pilbeam C
PLoS One; 2015; 10(3):e0120164. PubMed ID: 25781979
[TBL] [Abstract][Full Text] [Related]
3. Accentuated osteoclastic response to parathyroid hormone undermines bone mass acquisition in osteonectin-null mice.
Machado do Reis L; Kessler CB; Adams DJ; Lorenzo J; Jorgetti V; Delany AM
Bone; 2008 Aug; 43(2):264-273. PubMed ID: 18499553
[TBL] [Abstract][Full Text] [Related]
4. Do cyclooxygenase-2 knockout mice have primary hyperparathyroidism?
Xu M; Choudhary S; Goltzman D; Ledgard F; Adams D; Gronowicz G; Koczon-Jaremko B; Raisz L; Pilbeam C
Endocrinology; 2005 Apr; 146(4):1843-53. PubMed ID: 15625247
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro.
Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C
Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875
[TBL] [Abstract][Full Text] [Related]
6. Bone response to intermittent parathyroid hormone is altered in mice null for {beta}-Arrestin2.
Ferrari SL; Pierroz DD; Glatt V; Goddard DS; Bianchi EN; Lin FT; Manen D; Bouxsein ML
Endocrinology; 2005 Apr; 146(4):1854-62. PubMed ID: 15705780
[TBL] [Abstract][Full Text] [Related]
7. Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.
Choudhary S; Huang H; Raisz L; Pilbeam C
Biochem Biophys Res Commun; 2008 Aug; 372(4):536-41. PubMed ID: 18501188
[TBL] [Abstract][Full Text] [Related]
8. Sustained RANKL response to parathyroid hormone in oncostatin M receptor-deficient osteoblasts converts anabolic treatment to a catabolic effect in vivo.
Walker EC; Poulton IJ; McGregor NE; Ho PW; Allan EH; Quach JM; Martin TJ; Sims NA
J Bone Miner Res; 2012 Apr; 27(4):902-12. PubMed ID: 22190112
[TBL] [Abstract][Full Text] [Related]
9. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
Liu F; Lee SK; Adams DJ; Gronowicz GA; Kream BE
Bone; 2007 Apr; 40(4):1135-43. PubMed ID: 17275432
[TBL] [Abstract][Full Text] [Related]
10. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy-associated plasma protein-A modulates the anabolic effects of parathyroid hormone in mouse bone.
Clifton KB; Conover CA
Bone; 2015 Dec; 81():413-416. PubMed ID: 26297833
[TBL] [Abstract][Full Text] [Related]
12. beta-Arrestin2 regulates the differential response of cortical and trabecular bone to intermittent PTH in female mice.
Bouxsein ML; Pierroz DD; Glatt V; Goddard DS; Cavat F; Rizzoli R; Ferrari SL
J Bone Miner Res; 2005 Apr; 20(4):635-43. PubMed ID: 15765183
[TBL] [Abstract][Full Text] [Related]
13. Nmp4/CIZ suppresses parathyroid hormone-induced increases in trabecular bone.
Robling AG; Childress P; Yu J; Cotte J; Heller A; Philip BK; Bidwell JP
J Cell Physiol; 2009 Jun; 219(3):734-43. PubMed ID: 19189321
[TBL] [Abstract][Full Text] [Related]
14. Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism.
Novince CM; Michalski MN; Koh AJ; Sinder BP; Entezami P; Eber MR; Pettway GJ; Rosol TJ; Wronski TJ; Kozloff KM; McCauley LK
J Bone Miner Res; 2012 Jan; 27(1):11-25. PubMed ID: 21932346
[TBL] [Abstract][Full Text] [Related]
15. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the aldehyde dehydrogenase 2 gene increases the bone anabolic response to intermittent PTH treatment in an ovariectomized mouse model.
Kosugi K; Tajima T; Menuki K; Okuma KF; Tokuda K; Fukuda H; Okada Y; Tsukamoto M; Yamanaka Y; Zenke Y; Sakai A
Bone; 2020 Jul; 136():115370. PubMed ID: 32325250
[TBL] [Abstract][Full Text] [Related]
17. Mice lacking bone sialoprotein (BSP) lose bone after ovariectomy and display skeletal site-specific response to intermittent PTH treatment.
Wade-Gueye NM; Boudiffa M; Laroche N; Vanden-Bossche A; Fournier C; Aubin JE; Vico L; Lafage-Proust MH; Malaval L
Endocrinology; 2010 Nov; 151(11):5103-13. PubMed ID: 20844009
[TBL] [Abstract][Full Text] [Related]
18. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone.
Yang D; Singh R; Divieti P; Guo J; Bouxsein ML; Bringhurst FR
Bone; 2007 Jun; 40(6):1453-61. PubMed ID: 17376756
[TBL] [Abstract][Full Text] [Related]
19. Continuous PTH in Male Mice Causes Bone Loss Because It Induces Serum Amyloid A.
Choudhary S; Santone E; Yee SP; Lorenzo J; Adams DJ; Goetjen A; McCarthy MB; Mazzocca AD; Pilbeam C
Endocrinology; 2018 Jul; 159(7):2759-2776. PubMed ID: 29757436
[TBL] [Abstract][Full Text] [Related]
20. Beta-Arrestin2 regulates RANKL and ephrins gene expression in response to bone remodeling in mice.
Pierroz DD; Rufo A; Bianchi EN; Glatt V; Capulli M; Rucci N; Cavat F; Rizzoli R; Teti A; Bouxsein ML; Ferrari SL
J Bone Miner Res; 2009 May; 24(5):775-84. PubMed ID: 19113915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
